Cargando…
Liver transplantation in elderly patients: what do we know at the beginning of 2020?
An aging population has prompted us to evaluate the indications of liver transplantation (LT) in elderly patients more frequently. In this review, we summarize the short- and long-term results after LT in elderly patients and also discuss the criteria used to select patients and how recipient age ca...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239827/ https://www.ncbi.nlm.nih.gov/pubmed/32279191 http://dx.doi.org/10.1007/s00595-020-01996-7 |
_version_ | 1783536757775532032 |
---|---|
author | Dolnikov, Shimon Adam, René Cherqui, Daniel Allard, Marc Antoine |
author_facet | Dolnikov, Shimon Adam, René Cherqui, Daniel Allard, Marc Antoine |
author_sort | Dolnikov, Shimon |
collection | PubMed |
description | An aging population has prompted us to evaluate the indications of liver transplantation (LT) in elderly patients more frequently. In this review, we summarize the short- and long-term results after LT in elderly patients and also discuss the criteria used to select patients and how recipient age can challenge current allocation systems. Briefly, the feasibility and early outcomes of LT in elderly patients compare favorably with those of younger patients. Although long-term survival is less than satisfactory, large-scale studies show that the transplant survival benefit is similar for elderly and younger patients. Therefore, age alone does not contraindicate LT; however, screening for cardiopulmonary comorbidities, and asymptomatic malignancies, evaluating nutritional status, and frailty, is crucial to ensure optimal results and avoid futile transplantation. |
format | Online Article Text |
id | pubmed-7239827 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Singapore |
record_format | MEDLINE/PubMed |
spelling | pubmed-72398272020-05-27 Liver transplantation in elderly patients: what do we know at the beginning of 2020? Dolnikov, Shimon Adam, René Cherqui, Daniel Allard, Marc Antoine Surg Today Review Article An aging population has prompted us to evaluate the indications of liver transplantation (LT) in elderly patients more frequently. In this review, we summarize the short- and long-term results after LT in elderly patients and also discuss the criteria used to select patients and how recipient age can challenge current allocation systems. Briefly, the feasibility and early outcomes of LT in elderly patients compare favorably with those of younger patients. Although long-term survival is less than satisfactory, large-scale studies show that the transplant survival benefit is similar for elderly and younger patients. Therefore, age alone does not contraindicate LT; however, screening for cardiopulmonary comorbidities, and asymptomatic malignancies, evaluating nutritional status, and frailty, is crucial to ensure optimal results and avoid futile transplantation. Springer Singapore 2020-04-11 2020 /pmc/articles/PMC7239827/ /pubmed/32279191 http://dx.doi.org/10.1007/s00595-020-01996-7 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Review Article Dolnikov, Shimon Adam, René Cherqui, Daniel Allard, Marc Antoine Liver transplantation in elderly patients: what do we know at the beginning of 2020? |
title | Liver transplantation in elderly patients: what do we know at the beginning of 2020? |
title_full | Liver transplantation in elderly patients: what do we know at the beginning of 2020? |
title_fullStr | Liver transplantation in elderly patients: what do we know at the beginning of 2020? |
title_full_unstemmed | Liver transplantation in elderly patients: what do we know at the beginning of 2020? |
title_short | Liver transplantation in elderly patients: what do we know at the beginning of 2020? |
title_sort | liver transplantation in elderly patients: what do we know at the beginning of 2020? |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239827/ https://www.ncbi.nlm.nih.gov/pubmed/32279191 http://dx.doi.org/10.1007/s00595-020-01996-7 |
work_keys_str_mv | AT dolnikovshimon livertransplantationinelderlypatientswhatdoweknowatthebeginningof2020 AT adamrene livertransplantationinelderlypatientswhatdoweknowatthebeginningof2020 AT cherquidaniel livertransplantationinelderlypatientswhatdoweknowatthebeginningof2020 AT allardmarcantoine livertransplantationinelderlypatientswhatdoweknowatthebeginningof2020 |